Top Decentralized Clinical Trial Platforms
Decentralized Clinical Trials (DCTs), in which clinical trial data is collected through sensors or remote monitoring devices, can deliver many benefits to pharmaceutical companies, including cost savings, better patient recruitment and retention, flexibility in operations, and improved data quality. Before the pandemic, although the technology and data to support DCTs existed, only a few pilots were conducted. Today, the pressing need for remote patient- and site-centric trials has increased investments in DCTs by pharma enterprises, and the momentum is expected to accelerate going forward, indicating that DCTs are here to stay. Additionally, technology advances, innovative business models, increased wearables support, US FDA’s push to adopt DCTs, and a holistic approach to clinical trials have strengthened the DCT landscape.
In this report, we assess the capabilities of 24 DCT platform providers. The providers are positioned on Everest Group’s PEAK Matrix®, a composite index of a range of distinct metrics related to the providers’ capabilities and market impact. The study will enable buyers to choose the best-fit provider based on their sourcing considerations, while providers will be able to benchmark their performance against each other.
What is in this PEAK Matrix® Report:
In this report, we examine the provider landscape for DCTs and assess DCT platform providers on several capabilities and market success-related dimensions.
Industry: life sciences
Impact of Revenue Management Outsourcing Models on Life Sciences Enterprises by Size
Life Sciences Enterprises’ Sourcing Criteria for Selecting BPO Providers
Benefits of Outsourcing Revenue Management Processes for Life Sciences Enterprises
Key Implications of Generative AI in Life Sciences Commercial Technology
What is the PEAK Matrix®?
The PEAK Matrix® provides an objective, data-driven assessment of service and technology providers based on their overall capability and market impact across different global services markets, classifying them into three categories: Leaders, Major Contenders, and Aspirants.